Page last updated: 2024-11-04

suramin and Adrenal Cortex Neoplasms

suramin has been researched along with Adrenal Cortex Neoplasms in 10 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Adrenal Cortex Neoplasms: Tumors or cancers of the ADRENAL CORTEX.

Research Excerpts

ExcerptRelevanceReference
"The efficacy of mitotane in providing objective tumour responses in patients with adrenocortical carcinoma (ACC), has been recently questioned."6.17Cytotoxic chemotherapy for adrenocortical carcinoma. ( Alì, A; Angeli, A; Berruti, A; Dogliotti, L; Paccotti, P; Pia, A, 1995)
"Treatment with suramin (Germanin) was begun in August 1987."5.28[Treatment of metastatic adrenal carcinoma with suramin]. ( Allolio, B; Arlt, W; Jaursch-Hancke, C; Metzler, U; Reincke, M; Winkelmann, W, 1989)
"(1) Suramin is of antineoplastic efficacy in the treatment of metastatic adrenocortical carcinoma."3.69Suramin in adrenocortical cancer: limited efficacy and serious toxicity. ( Allolio, B; Arlt, W; Reincke, M; Siekmann, L; Winkelmann, W, 1994)
"Treatment with suramin (Germanin) was begun in August 1987."1.28[Treatment of metastatic adrenal carcinoma with suramin]. ( Allolio, B; Arlt, W; Jaursch-Hancke, C; Metzler, U; Reincke, M; Winkelmann, W, 1989)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's6 (60.00)18.2507
2000's0 (0.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa, R1
Wesolowski, R1
Raghavan, D1
Dogliotti, L1
Berruti, A1
Pia, A1
Paccotti, P1
Alì, A1
Angeli, A1
Arlt, W3
Reincke, M3
Siekmann, L2
Winkelmann, W3
Allolio, B4
Höfle, G1
Gasser, RW1
Lhotta, K1
Janetschek, G1
Kreczy, A1
Finkenstedt, G1
May, E1
Wellstein, A1
Lupu, R1
Zugmaier, G1
Flamm, SL1
Cheville, AL1
Delli Bovi, P1
Basilico, C1
Lippman, ME1
Kern, FG1
La Rocca, RV1
Stein, CA2
Danesi, R1
Jamis-Dow, CA1
Weiss, GH1
Myers, CE2
Deuss, U1
Jaursch-Hancke, C1
Metzler, U1
LaRocca, RV1
Thomas, R1
McAtee, N1

Reviews

2 reviews available for suramin and Adrenal Cortex Neoplasms

ArticleYear
Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?
    BJU international, 2011, Volume: 108, Issue:10

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents; Antineoplastic Combined C

2011
Cytotoxic chemotherapy for adrenocortical carcinoma.
    Minerva endocrinologica, 1995, Volume: 20, Issue:1

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols

1995

Trials

1 trial available for suramin and Adrenal Cortex Neoplasms

ArticleYear
Cytotoxic chemotherapy for adrenocortical carcinoma.
    Minerva endocrinologica, 1995, Volume: 20, Issue:1

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols

1995

Other Studies

8 other studies available for suramin and Adrenal Cortex Neoplasms

ArticleYear
Suramin in adrenocortical cancer: limited efficacy and serious toxicity.
    Clinical endocrinology, 1994, Volume: 41, Issue:3

    Topics: Adrenal Cortex Neoplasms; Adult; Aged; Blood Coagulation; Bone Marrow; Carcinoma; Drug Eruptions; Fe

1994
Adrenocortical carcinoma evolving after diagnosis of preclinical Cushing's syndrome in an adrenal incidentaloma. A case report.
    Hormone research, 1998, Volume: 50, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Androgens; Antineoplastic Combined Chemotherapy Prot

1998
Fatal toxic epidermal necrolysis during suramin therapy.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:10

    Topics: Adrenal Cortex Neoplasms; Female; Humans; Middle Aged; Stevens-Johnson Syndrome; Suramin

1991
Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1990, Volume: 1, Issue:2

    Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Animals; Down-Regulation; Fibroblast Growth Factor 2; Fibr

1990
Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:2

    Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Animals; Antineoplastic Agents; Cell Line; Fe

1990
Suramin for treatment of adrenocortical carcinoma.
    Lancet (London, England), 1989, Jul-29, Volume: 2, Issue:8657

    Topics: Adrenal Cortex Neoplasms; Adult; Carcinoma; Female; Humans; Male; Middle Aged; Suramin

1989
[Treatment of metastatic adrenal carcinoma with suramin].
    Deutsche medizinische Wochenschrift (1946), 1989, Mar-10, Volume: 114, Issue:10

    Topics: Adrenal Cortex Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modali

1989
Suramin: an anticancer drug with a unique mechanism of action.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:4

    Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adult; Antineoplastic Agents; Carcinoma; Female; Humans; K

1989